Computational Approaches for Pharmacovigilance Signal Detection: Toward Integrated and Semantically-Enriched Frameworks
暂无分享,去创建一个
[1] Ryen W. White,et al. Toward Enhanced Pharmacovigilance Using Patient-Generated Data on the Internet , 2014, Clinical pharmacology and therapeutics.
[2] Patrick B. Ryan,et al. Big data, big results: Knowledge discovery in output from large‐scale analytics , 2014, Stat. Anal. Data Min..
[3] David Madigan,et al. Empirical Performance of the Self-Controlled Case Series Design: Lessons for Developing a Risk Identification and Analysis System , 2013, Drug Safety.
[4] Richard Platt,et al. The U.S. Food and Drug Administration's Mini‐Sentinel Program , 2012 .
[5] Patrick B. Ryan,et al. Empirical Performance of a Self-Controlled Cohort Method: Lessons for Developing a Risk Identification and Analysis System , 2013, Drug Safety.
[6] Hongfang Liu,et al. Standardizing adverse drug event reporting data , 2014, J. Biomed. Semant..
[7] M. Schuemie,et al. Defining a Reference Set to Support Methodological Research in Drug Safety , 2013, Drug Safety.
[8] Russ B. Altman,et al. A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports , 2012, J. Am. Medical Informatics Assoc..
[9] G. Omenn,et al. Ontology-Based Combinatorial Comparative Analysis of Adverse Events Associated with Killed and Live Influenza Vaccines , 2012, PloS one.
[10] William DuMouchel,et al. Evaluation of Disproportionality Safety Signaling Applied to Healthcare Databases , 2013, Drug Safety.
[11] Noémie Elhadad,et al. Natural Language Processing in Health Care and Biomedicine , 2014 .
[12] Patrick B. Ryan,et al. Managing Data Quality for a Drug Safety Surveillance System , 2013, Drug Safety.
[13] Yon Dohn Chung,et al. A framework to preserve the privacy of electronic health data streams , 2014, J. Biomed. Informatics.
[14] Carol Friedman,et al. Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactions , 2013, J. Am. Medical Informatics Assoc..
[15] Christopher D. Manning,et al. Introduction to Information Retrieval , 2010, J. Assoc. Inf. Sci. Technol..
[16] G. Niklas Norén,et al. A Decade of Data Mining and Still Counting , 2010, Drug safety.
[17] M. Harrison‐Woolrych. Evaluating medicines: let's use all the evidence , 2007, The Medical journal of Australia.
[18] D. Madigan,et al. Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership , 2012, Statistics in medicine.
[19] Régis Beuscart,et al. Data Mining to Generate Adverse Drug Events Detection Rules , 2011, IEEE Transactions on Information Technology in Biomedicine.
[20] Michel Dumontier,et al. Ontology-Based Querying with Bio2RDF’s Linked Open Data , 2013, Journal of Biomedical Semantics.
[21] Hua Xu,et al. Identifying Plausible Adverse Drug Reactions Using Knowledge Extracted from the Literature , 2014, AMIA.
[22] Brent I. Fox,et al. How Well Do Various Health Outcome Definitions Identify Appropriate Cases in Observational Studies? , 2013, Drug Safety.
[23] N. Shah,et al. Performance of Pharmacovigilance Signal‐Detection Algorithms for the FDA Adverse Event Reporting System , 2013, Clinical pharmacology and therapeutics.
[24] Martijn J. Schuemie,et al. Using Electronic Health Care Records for Drug Safety Signal Detection: A Comparative Evaluation of Statistical Methods , 2012, Medical care.
[25] C. Friedman,et al. Detection of Pharmacovigilance‐Related Adverse Events Using Electronic Health Records and Automated Methods , 2012, Clinical pharmacology and therapeutics.
[26] Uwe Aickelin,et al. Comparison of algorithms that detect drug side effects using electronic healthcare databases , 2013, Soft Comput..
[27] James A. Hendler,et al. Handbook of Semantic Web Technologies , 2011, Handbook of Semantic Web Technologies.
[28] Manfred Hauben,et al. A conceptual approach to the masking effect of measures of disproportionality , 2014, Pharmacoepidemiology and drug safety.
[29] David Madigan,et al. Empirical Performance of a New User Cohort Method: Lessons for Developing a Risk Identification and Analysis System , 2013, Drug Safety.
[30] M. Lindquist,et al. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions , 2002, Pharmacoepidemiology and drug safety.
[31] Hua Xu,et al. Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs , 2012, J. Am. Medical Informatics Assoc..
[32] Susie Stephens,et al. Applying semantic Web technologies to drug safety determination , 2006, IEEE Intelligent Systems.
[33] Marie-Christine Jaulent,et al. Formalizing MedDRA to support semantic reasoning on adverse drug reaction terms , 2014, J. Biomed. Informatics.
[34] G. Niklas Norén,et al. Improved Statistical Signal Detection in Pharmacovigilance by Combining Multiple Strength-of-Evidence Aspects in vigiRank , 2014, Drug Safety.
[35] Hua Xu,et al. Comparative analysis of pharmacovigilance methods in the detection of adverse drug reactions using electronic medical records , 2013, J. Am. Medical Informatics Assoc..
[36] I. Pigeot,et al. Signal Detection and Monitoring Based on Longitudinal Healthcare Data , 2012, Pharmaceutics.
[37] M. Lindquist. Use of Triage Strategies in the WHO Signal-Detection Process , 2007, Drug safety.
[38] eHealth for Safety Impact of ICT on Patient Safety and Risk Management , 2007 .
[39] Vincent Bauchau,et al. Signal detection on spontaneous reports of adverse events following immunisation: a comparison of the performance of a disproportionality-based algorithm and a time-to-onset-based algorithm , 2014, Pharmacoepidemiology and drug safety.
[40] P Ryan,et al. Novel Data‐Mining Methodologies for Adverse Drug Event Discovery and Analysis , 2012, Clinical pharmacology and therapeutics.
[41] Patrice Degoulet,et al. Implementation of automated signal generation in pharmacovigilance using a knowledge-based approach , 2005, Int. J. Medical Informatics.
[42] D. Madigan,et al. The role of data mining in pharmacovigilance , 2005, Expert opinion on drug safety.
[43] Anders Sundström,et al. Factors Predisposing an Abstract To Be Accepted for Oral Presentation , 2008 .
[44] Christophe G. Lambert,et al. Bridging Islands of Information to Establish an Integrated Knowledge Base of Drugs and Health Outcomes of Interest , 2014, Drug Safety.
[45] Patrick B. Ryan,et al. Alternative Outcome Definitions and Their Effect on the Performance of Methods for Observational Outcome Studies , 2013, Drug Safety.
[46] Ying Li,et al. A method for controlling complex confounding effects in the detection of adverse drug reactions using electronic health records , 2014, J. Am. Medical Informatics Assoc..
[47] Martijn J Schuemie,et al. Methods for drug safety signal detection in longitudinal observational databases: LGPS and LEOPARD , 2011, Pharmacoepidemiology and drug safety.
[48] David Madigan,et al. Empirical Performance of the Case–Control Method: Lessons for Developing a Risk Identification and Analysis System , 2013, Drug Safety.
[49] Siddhartha R. Dalal,et al. Using information mining of the medical literature to improve drug safety , 2011, J. Am. Medical Informatics Assoc..
[50] Vassilis Koutkias,et al. Leveraging Post-marketing Drug Safety Research through Semantic Technologies: The PharmacoVigilance Signal Detectors Ontology , 2014, SWAT4LS.
[51] N. Shah,et al. Pharmacovigilance Using Clinical Notes , 2013, Clinical pharmacology and therapeutics.
[52] A. Pariente,et al. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor? , 2009, Pharmacoepidemiology and drug safety.
[53] Patrick B. Ryan,et al. Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases , 2010, J. Am. Medical Informatics Assoc..
[54] David Madigan,et al. Disproportionality methods for pharmacovigilance in longitudinal observational databases , 2013, Statistical methods in medical research.
[55] Andrew M. Jenkinson,et al. The EBI RDF platform: linked open data for the life sciences , 2014, Bioinform..
[56] G Niklas Norén,et al. Pharmacovigilance for a Revolving World: Prospects of Patient-Generated Data on the Internet , 2014, Drug Safety.
[57] Sally Okun,et al. Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium Guidance , 2013, Drug Safety.
[58] G. N. Norén,et al. The Development and Evaluation of Triage Algorithms for Early Discovery of Adverse Drug Interactions , 2013, Drug Safety.
[59] Taha A. Kass-Hout,et al. Digital Drug Safety Surveillance: Monitoring Pharmaceutical Products in Twitter , 2014, Drug Safety.
[60] Prakash M. Nadkarni,et al. Overcoming barriers to NLP for clinical text: the role of shared tasks and the need for additional creative solutions , 2011, J. Am. Medical Informatics Assoc..
[61] G. Niklas Norén,et al. Temporal pattern discovery in longitudinal electronic patient records , 2010, Data Mining and Knowledge Discovery.
[62] Yen S. Low,et al. Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art , 2014, Drug Safety.
[63] G Declerck,et al. Bridging Data Models and Terminologies to Support Adverse Drug Event Reporting Using EHR Data , 2014, Methods of Information in Medicine.
[64] A Bate,et al. Decision support methods for the detection of adverse events in post-marketing data. , 2009, Drug discovery today.
[65] Z. Bankowski,et al. Council for International Organizations of Medical Sciences , 1991 .
[66] M. Schuemie,et al. Variation in Choice of Study Design: Findings from the Epidemiology Design Decision Inventory and Evaluation (EDDIE) Survey , 2013, Drug Safety.